A systematic review of adherence to iron chelation therapy among children and adolescents with thalassemia

New insights to improve treatment adherence in asthma and COPD

(2019) Maureen George et al.   Patient Preference and Adherence

Association between day of the week and medication adherence among adolescent and young adult kidney transplant recipients

(2019) Julie Boucquemont et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Combination Oral Chelation in Adult Patients With Transfusion-dependent Thalassemia and High Iron Burden

(2018) John Hammond et al.   JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY

Beliefs and Adherence Associated With Oral and Infusion Chelation Therapies in Jordanian Children and Adolescents With Thalassemia Major

(2018) Ghada M. Abu Shosha   JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY

Utilizing a Novel Mobile Health “Selfie” Application to Improve Compliance to Iron Chelation in Pediatric Patients Receiving Chronic Transfusions

(2017) Sarah Leonard et al.   JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY

Accuracy of a screening tool for medication adherence: A systematic review and meta-analysis of the Morisky Medication Adherence Scale-8

(2017) Sun Jae Moon et al.   PLoS One

Efficacy and safety of a novel combination of two oral chelators deferasirox/deferiprone over deferoxamine/deferiprone in severely iron overloaded young beta thalassemia major patients

(2015) Mohsen S. Elalfy et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Predictors of Non-Adherence to Follow-up Visits and Deferasirox Chelation Therapy Among Jordanian Adolescents with Thalassemia Major

(2014) Manal Ibrahim Al-Kloub et al.   PEDIATRIC HEMATOLOGY AND ONCOLOGY

Deferiprone (GPO-L-ONE®) monotherapy reduces iron overload in transfusion-dependent thalassemias: 1-year results from a multicenter prospective, single arm, open label, dose escalating phase III pediatric study (GPO-L-ONE; A001) from Thailand

(2013) Vip Viprakasit et al.   AMERICAN JOURNAL OF HEMATOLOGY

Impact of psychosocial status and disease knowledge on deferoxamine adherence among thalassaemia major adolescents

(2013) Manal Ibrahim Al-Kloub et al.   International Journal of Nursing Practice

Morbidities and Mortality in Transfusion-Dependent Beta-Thalassemia Patients (Single-Center Experience)

(2013) Galila M. Mokhtar et al.   PEDIATRIC HEMATOLOGY AND ONCOLOGY

Efficacy of Deferasirox for the treatment of iron overload in Chinese thalassaemia major patients: results from a prospective, open-label, multicentre clinical trial

(2013) Y.-R. Lai et al.   TRANSFUSION MEDICINE

A new tool for the assessment of satisfaction with iron chelation therapy (ICT-Sat) for patients with β-thalassemia major

(2012) Mohsen S. Elalfy et al.   PEDIATRIC BLOOD & CANCER

Suitability of measures of self-reported medication adherence for routine clinical use: A systematic review

(2011) Sara Garfield et al.   BMC Medical Research Methodology

Self-reported level of and factors influencing the compliance to desferrioxamine therapy in multitransfused thalassaemias

(2011) Way Seah Lee et al.   JOURNAL OF PAEDIATRICS AND CHILD HEALTH

Improved Treatment Satisfaction and Convenience with Deferasirox in Iron-Overloaded Patients with β-Thalassemia: Results from the ESCALATOR Trial

(2010) Ali Taher et al.   ACTA HAEMATOLOGICA

Beta-thalassemia

(2010) Antonio Cao et al.   GENETICS IN MEDICINE

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

(2009) David Moher et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Iron chelation therapy: Clinical effectiveness, economic burden and quality of life in patients with iron overload

(2008) Krista A. Payne et al.   ADVANCES IN THERAPY

Iron chelation in thalassemia: combined or monotherapy? The Egyptian experience

(2008) Amal El-Beshlawy et al.   ANNALS OF HEMATOLOGY

Disease knowledge and treatment adherence among patients with thalassemia major and their mothers in Taiwan

(2008) Ya-Ling Lee et al.   JOURNAL OF CLINICAL NURSING